Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Averback Paul
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Nymox Pharmaceutical Corporation
Nymox Pharmaceutical Corporation
CEO, Director, 10% Owner
Avg. Two Year Performance
No Purchase Track Record
(31%)
Avg. Sale Return
(14%)
Compound
Holdings:
21.64M
shares
Last Three Months: 14-Feb-24 -- 13-May-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Diagnostic Substances
Drugs
Two Year Chart
14-May-22 -- 13-May-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions